116 related articles for article (PubMed ID: 28895340)
21. Kai-Xin-San, a standardized traditional Chinese medicine formula, up-regulates the expressions of synaptic proteins on hippocampus of chronic mild stress induced depressive rats and primary cultured rat hippocampal neuron.
Zhu Y; Duan X; Cheng X; Cheng X; Li X; Zhang L; Liu P; Su S; Duan JA; Dong TT; Tsim KW; Huang F
J Ethnopharmacol; 2016 Dec; 193():423-432. PubMed ID: 27660009
[TBL] [Abstract][Full Text] [Related]
22. High-throughput screening for monoamine oxidase-A and monoamine oxidase-B inhibitors using one-step fluorescence assay.
Guang HM; Du GH
Acta Pharmacol Sin; 2006 Jun; 27(6):760-6. PubMed ID: 16723097
[TBL] [Abstract][Full Text] [Related]
23. Antidepressant-like effects of water extract of Gastrodia elata Blume in rats exposed to unpredictable chronic mild stress via modulation of monoamine regulatory pathways.
Lin YE; Lin SH; Chen WC; Ho CT; Lai YS; Panyod S; Sheen LY
J Ethnopharmacol; 2016 Jul; 187():57-65. PubMed ID: 27109341
[TBL] [Abstract][Full Text] [Related]
24. Effect of lamotrigine on the activities of monoamine oxidases A and B in vitro and on monoamine disposition in vivo.
Southam E; Pereira R; Stratton SC; Sargent R; Ford AJ; Butterfield LJ; Wheable JD; Beckett SR; Roe C; Marsden CA; Hagan RM
Eur J Pharmacol; 2005 Sep; 519(3):237-45. PubMed ID: 16129425
[TBL] [Abstract][Full Text] [Related]
25. Preventive action of Kai Xin San aqueous extract on depressive-like symptoms and cognition deficit induced by chronic mild stress.
Dang H; Sun L; Liu X; Peng B; Wang Q; Jia W; Chen Y; Pan A; Xiao P
Exp Biol Med (Maywood); 2009 Jul; 234(7):785-93. PubMed ID: 19429857
[TBL] [Abstract][Full Text] [Related]
26. Kai‑Xin‑San suppresses matrix metalloproteinases and myocardial apoptosis in rats with myocardial infarction and depression.
Hu Y; Dong X; Zhang T; Ma H; Yang W; Wang Y; Liu P; Chen Y
Mol Med Rep; 2020 Jan; 21(1):508-516. PubMed ID: 31746394
[TBL] [Abstract][Full Text] [Related]
27. Anti-depressive effects of Kai-Xin-San on lipid metabolism in depressed patients and CUMS rats using metabolomic analysis.
Zhou X; Wang J; Lu Y; Chen C; Hu Y; Liu P; Dong X
J Ethnopharmacol; 2020 Apr; 252():112615. PubMed ID: 31991203
[TBL] [Abstract][Full Text] [Related]
28. Ecstasy-induced oxidative stress to adolescent rat brain mitochondria in vivo: influence of monoamine oxidase type A.
Alves E; Summavielle T; Alves CJ; Custódio JB; Fernandes E; de Lourdes Bastos M; Tavares MA; Carvalho F
Addict Biol; 2009 Apr; 14(2):185-93. PubMed ID: 19076925
[TBL] [Abstract][Full Text] [Related]
29. Antidepressant-like effect of the ethanolic extract from Suanzaorenhehuan Formula in mice models of depression.
Liu J; Qiao W; Yang Y; Ren L; Sun Y; Wang S
J Ethnopharmacol; 2012 May; 141(1):257-64. PubMed ID: 22366432
[TBL] [Abstract][Full Text] [Related]
30. Possible mechanism of the antidepressant effect of 3,6'-disinapoyl sucrose from Polygala tenuifolia Willd.
Hu Y; Liu M; Liu P; Guo DH; Wei RB; Rahman K
J Pharm Pharmacol; 2011 Jun; 63(6):869-74. PubMed ID: 21585386
[TBL] [Abstract][Full Text] [Related]
31. High-throughput lipidomics characterize key lipid molecules as potential therapeutic targets of Kaixinsan protects against Alzheimer's disease in APP/PS1 transgenic mice.
Gao HL; Zhang AH; Yu JB; Sun H; Kong L; Wang XQ; Yan GL; Liu L; Wang XJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1092():286-295. PubMed ID: 29933222
[TBL] [Abstract][Full Text] [Related]
32. [Effect of various antidepressive agents on brain monoamine oxidase activity].
Gankina EM; Moskvitina TA; Gorkin VZ; Val'dman AV
Biull Eksp Biol Med; 1982 Nov; 94(11):29-31. PubMed ID: 7150732
[TBL] [Abstract][Full Text] [Related]
33. Time-dependent changes in brain monoamine oxidase activity and in brain levels of monoamines and amino acids following acute administration of the antidepressant/antipanic drug phenelzine.
Parent MB; Habib MK; Baker GB
Biochem Pharmacol; 2000 May; 59(10):1253-63. PubMed ID: 10736426
[TBL] [Abstract][Full Text] [Related]
34. [Effect of centrophenoxine, piracetam and aniracetam on the monoamine oxidase activity in different brain structures of rats].
Stancheva SL; Alova LG
Farmakol Toksikol; 1988; 51(3):16-8. PubMed ID: 3137089
[TBL] [Abstract][Full Text] [Related]
35. Zinc benzoate, a contaminating environmental compound derived from polystyrene resin inhibits A-type monoamine oxidase.
Egashira T; Sakai K; Takayama F; Sakurai M; Yoshida S
Toxicol Lett; 2003 Nov; 145(2):161-5. PubMed ID: 14581168
[TBL] [Abstract][Full Text] [Related]
36. The properties of B-form monoamine oxidase in mitochondria from monkey platelet.
Obata T; Aomine M
Res Commun Mol Pathol Pharmacol; 2009-2010; 122-123():13-26. PubMed ID: 25022028
[TBL] [Abstract][Full Text] [Related]
37. Novel bifunctional drugs targeting monoamine oxidase inhibition and iron chelation as an approach to neuroprotection in Parkinson's disease and other neurodegenerative diseases.
Youdim MB; Fridkin M; Zheng H
J Neural Transm (Vienna); 2004 Oct; 111(10-11):1455-71. PubMed ID: 15480846
[TBL] [Abstract][Full Text] [Related]
38. [Inhibitory effect of hypoxanthine on monoamine oxidase activity].
Wang BX; Chen XG
Yao Xue Xue Bao; 1989; 24(8):573-7. PubMed ID: 2618701
[TBL] [Abstract][Full Text] [Related]
39. Effects of zinc ion on type A monoamine oxidase in monkey brain mitochondria.
Egashira T; Takayama F; Sakai K
Biochem Pharmacol; 2003 Feb; 65(4):625-7. PubMed ID: 12566091
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation.
Youdim MB; Weinstock M
Neurotoxicology; 2004 Jan; 25(1-2):243-50. PubMed ID: 14697899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
